(Q40338086)

English

Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells

scientific article published on December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Hidetake Matsuyoshi

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Shinya Hirata

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yoshihiro Yoshitake

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yutaka Motomura

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Daiki Fukuma

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Akari Kurisaki

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tetsuya Nakatsura

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yasuharu Nishimura

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Satoru Senju

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

889-896

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Directed differentiation of dendritic cells from mouse embryonic stem cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

A novel ES cell line, TT2, with high germline-differentiating potency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Immunocytochemical analyses and targeted gene disruption of GTPBP1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00123.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2005.00123.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40338086&oldid=2093979915"